SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-19-029989
Filing Date
2019-05-16
Accepted
2019-05-16 16:04:42
Documents
2
Period of Report
2019-05-10
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a19-10096_18k.htm 8-K 39030
2 EX-99.1 a19-10096_1ex99d1.htm EX-99.1 24113
  Complete submission text file 0001104659-19-029989.txt   64462
Mailing Address 375 PHEASANT RUN NEWTOWN PA 18940
Business Address 375 PHEASANT RUN NEWTOWN PA 18940 267-759-3681
Onconova Therapeutics, Inc. (Filer) CIK: 0001130598 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36020 | Film No.: 19832223
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1